Buy or sell stocks, Sept. 27 -- Following the escalation in trade worries after Trump's 100% pharma tariff, the key benchmark indices of the Indian stock market ended lower for the seventh straight session on Friday last week. The Nifty 50 index moved from 25,423 to 24,654 in these seven successive sessions, logging over 750 points or around 3% dip in this sharp selling. The BSE Sensex has shrunk from 83,013 to 80,426 levels, recording 2,767 points or a 3.33% dip. Trump's pharma tariffs, H-1B visa fee hike and weakness in the Indian National Rupee (INR) against the US Dollar (USD) are some of the primary reasons that have been dragging the key Indian benchmark indices.

Sumeet Bagadia, Executive Director at Choice Broking, believes the In...